Skip to main content

Root Jonathan D's Form 4 filing

eFFECTOR Therapeutics, Inc. · filed May 11, 2022

Accession no.
0001062993-22-012169
Filed
May 11, 2022, 8:10 PM ET
Trade date
May 9-11, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $118.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Root Jonathan DCIK 000122548010% Owner
US Venture Partners X LPCIK 000144051410% Owner
Usvp X Affiliates LPCIK 000145335910% Owner
Tansey Casey MCIK 000147432210% Owner
Presidio Management Group X LLCCIK 000160274410% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 9, 2022Common StockSSaleDisposed−3,876$2.54−$9,829.544,380,425Indirect
May 9, 2022Common StockSSaleDisposed−124$2.54−$314.59140,137Indirect
May 10, 2022Common StockSSaleDisposed−38,743$2.41−$93,486.864,341,682Indirect
May 10, 2022Common StockSSaleDisposed−1,241$2.41−$2,994.53138,896Indirect
May 11, 2022Common StockSSaleDisposed−4,845$2.35−$11,361.534,336,837Indirect
May 11, 2022Common StockSSaleDisposed−155$2.35−$363.63138,741Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)